Prevalence and associated characteristics of anti-SARS-CoV-2 antibodies in Mexico 5 months after pandemic arrival

BACKGROUND: Seroprevalence of anti-SARS-CoV-2 antibodies is now available in several world regions to better estimate transmission dynamics. However, to date, there is no epidemiological data regarding anti-SARS-CoV-2 prevalence in Mexico. Therefore, we aimed to determine the prevalence of anti-SARS...

Descripción completa

Detalles Bibliográficos
Autores principales: Díaz-Salazar, Cristina, Sánchez-García, Adriana, Rodríguez-Gutiérrez, René, Camacho-Ortiz, Adrián, Saldívar-Rodríguez, Donato, González-González, José Gerardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8374409/
https://www.ncbi.nlm.nih.gov/pubmed/34412620
http://dx.doi.org/10.1186/s12879-021-06550-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8374409/
https://www.ncbi.nlm.nih.gov/pubmed/34412620
http://dx.doi.org/10.1186/s12879-021-06550-5

Ejemplares similares